Concentra Group Holdings Hits New 52-Week High at $28.86

Concentra Group Holdings Parent, Inc. has reached a significant milestone by hitting a new 52-week high of USD 28.86 on June 18, 2026. This achievement marks a notable increase from its 52-week low of USD 18.55, reflecting a robust performance over the past year. In the context of the broader market, Concentra's stock has outperformed the S&P 500, showcasing a 25.41% increase in its one-year performance. The company operates within the Pharmaceuticals & Biotechnology industry and holds a market capitalization of USD 2,717 million, categorizing it as a small-cap entity. Financially, Concentra Group Holdings has a price-to-earnings (P/E) ratio of 15.00, indicating its valuation relative to earnings. However, it is noteworthy that the company has a high debt-to-equity ratio of 4.01, which may raise considerations regarding its financial leverage. Additionally, the company currently does not offer a dividend yield. This recent price movement underscores the stock's dynamic activity and its position within the competitive landscape of the pharmaceuticals and biotechnology sector.